- Home
- DBVT vs USCB Comparison
DBVT vs USCB Comparison
Compare DBVT & USCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBVT
- USCB
- Stock Information
- Founded
- DBVT 2002
- USCB 2002
- Country
- DBVT France
- USCB United States
- Employees
- DBVT N/A
- USCB N/A
- Industry
- DBVT Biotechnology: Biological Products (No Diagnostic Substances)
- USCB Major Banks
- Sector
- DBVT Health Care
- USCB Finance
- Exchange
- DBVT Nasdaq
- USCB Nasdaq
- Market Cap
- DBVT 289.8M
- USCB 316.4M
- IPO Year
- DBVT N/A
- USCB 2021
- Fundamental
- Price
- DBVT $9.00
- USCB $16.17
- Analyst Decision
- DBVT Buy
- USCB Buy
- Analyst Count
- DBVT 4
- USCB 3
- Target Price
- DBVT $14.81
- USCB $20.33
- AVG Volume (30 Days)
- DBVT 27.3K
- USCB 23.8K
- Earning Date
- DBVT 07-29-2025
- USCB 07-24-2025
- Dividend Yield
- DBVT N/A
- USCB 2.47%
- EPS Growth
- DBVT N/A
- USCB 69.00
- EPS
- DBVT N/A
- USCB 1.47
- Revenue
- DBVT $3,800,000.00
- USCB $88,094,000.00
- Revenue This Year
- DBVT $1,743.46
- USCB $23.28
- Revenue Next Year
- DBVT $1,044.34
- USCB $7.02
- P/E Ratio
- DBVT N/A
- USCB $11.00
- Revenue Growth
- DBVT N/A
- USCB 32.06
- 52 Week Low
- DBVT $2.21
- USCB $13.84
- 52 Week High
- DBVT $12.78
- USCB $21.86
- Technical
- Relative Strength Index (RSI)
- DBVT 44.06
- USCB 40.40
- Support Level
- DBVT $8.51
- USCB $17.12
- Resistance Level
- DBVT $10.93
- USCB $18.96
- Average True Range (ATR)
- DBVT 0.71
- USCB 0.65
- MACD
- DBVT -0.15
- USCB -0.14
- Stochastic Oscillator
- DBVT 20.25
- USCB 1.06
About DBVT DBV Technologies S.A.
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
About USCB USCB Financial Holdings Inc.
USCB Financial Holdings Inc is a community bank. Through its network of branches and its online banking platform, it offers customers a wide range of financial products and services such as Personal and Business Checking, Savings, Credit Cards, and Real Estate Loans.